Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)168.41
  • Today's Change-1.76 / -1.03%
  • Shares traded1.02m
  • 1 Year change+8.09%
  • Beta0.5305
Data delayed at least 15 minutes, as of May 26 2023 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

AmerisourceBergen Corporation is a global pharmaceutical sourcing and distribution services company. The Company's U.S. Healthcare Solutions segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services. This segment consists of Alliance Healthcare, World Courier, Innomar, Profarma, and Profarma Specialty. The Company also focuses on specialty services and a global platform of pharma manufacturer services capabilities.

  • Revenue in USD (TTM)247.54bn
  • Net income in USD1.62bn
  • Incorporated2001
  • Employees39.00k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ABC:NYQ since
PharmaLex Holding GmbHDeal completed12 Sep 202212 Sep 2022Deal completed14.35%1.28bn
Data delayed at least 15 minutes, as of May 26 2023 21:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd10.17bn576.03m7.85bn24.25k14.351.72--0.77182.502.5044.2120.891.026.644.822,964,
Sinopharm Group Co Ltd78.02bn1.20bn10.52bn114.77k8.731.094.030.13483.023.02195.8424.141.588.983.525,325,
Shanghai Pharmaceuticals Holding Co Ltd34.16bn832.84m10.70bn47.88k14.081.22--0.31331.601.6066.2218.541.247.303.495,040,198.003.823.909.4210.1712.8713.673.072.861.0917.360.38831.207.4912.1310.289.795.999.93
Cardinal Health Inc198.66bn463.00m21.09bn46.50k47.40--17.520.10621.751.75746.15-8.714.6511.9618.704,272,301.001.09-1.603.83-3.963.364.390.2341-0.42680.519214.881.88--11.636.89-252.70--0.001.80
AmerisourceBergen Corp.247.54bn1.62bn34.10bn39.00k21.64121.0114.590.13777.787.781,189.741.394.2714.7312.216,347,251.002.700.727311.342.933.413.020.63270.16490.511111.220.9061104.7111.509.2710.3236.051.254.74
McKesson Corp276.71bn3.56bn52.61bn58.00k15.48--12.140.190125.0725.051,945.24-13.654.4113.7714.57--5.930.634926.282.214.475.041.350.16110.51318.461.36133.574.835.84218.41---0.770410.25
Data as of May 26 2023. Currency figures normalised to Amerisourcebergen Corp's reporting currency: US Dollar USD

Institutional shareholders

35.22%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202320.39m10.08%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 202310.26m5.07%
BlackRock Fund Advisorsas of 31 Mar 20238.87m4.39%
SSgA Funds Management, Inc.as of 31 Mar 20237.42m3.67%
JPMorgan Investment Management, Inc.as of 31 Mar 20236.16m3.05%
Boston Partners Global Investors, Inc.as of 31 Mar 20235.01m2.48%
Fidelity Management & Research Co. LLCas of 31 Mar 20234.04m2.00%
Geode Capital Management LLCas of 31 Mar 20233.39m1.68%
Bessemer Investment Management LLCas of 31 Mar 20233.08m1.52%
BlackRock Investment Management (UK) Ltd.as of 31 Mar 20232.60m1.29%
More ▼
Data from 31 Mar 2023 - 31 Mar 2023Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.